Merck‘s new HIV treatment recommended by FDA panel for approval: The advisory panel voted unanimously to recommend marketing approval for the twice-a-day pill, known generically as raltegravir, the first in a novel class of AIDS treatments to go before regulators…more
Pfizer‘s spin on Lipitor-switchers called into question: Why did more people die after switching from Lipitor to generic Zocor? This kind of “study” is great for headlines; maybe not for responsible clinical decision-making…more and more
Lots of prescriptions for bi-polar kids: Sales for children of antipsychotic medicines made by Johnson & Johnson, AstraZeneca Plc and Pfizer Inc. have exploded, fueled by a 40-fold increase over nine years in the number of children diagnosed with bipolar disorder…more
Cephalon gets orphan designation for its oncology drug Treanda (leukemia).
Anti-depressants and youth suicides – fewer prescriptions, more deaths?
The Medical Marketing and Media annual pharma sales/marketing salary survey report (2007) – free download here.